Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)
Clinical trial NCT04021290 · COMPLETED
Trial details
- NCT number
- NCT04021290
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-11
- Primary completion
- 2021-04-23
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.